Full Text View
Tabular View
No Study Results Posted
Related Studies
Vitamin D Metabolism and the Williams Syndrome
This study has been completed.
First Received: April 3, 2001   Last Updated: June 23, 2005   History of Changes
Sponsor: National Center for Research Resources (NCRR)
Information provided by: National Center for Research Resources (NCRR)
ClinicalTrials.gov Identifier: NCT00013962
  Purpose

The Williams syndrome is a disease in which supravalvular aortic stenosis, an elfin facies, mental retardation and other congenital defects are sometimes associated with abnormal vitamin D and calcium metabolism. Whereas some patients have been reported to show increased sensitivity to vitamin D or an exaggerated response of serum 25-hydroxyvitamin D {25(OH)D} to administration of vitamin D and to have hypercalcemia caused by increased circulating 1,25-dihydroxyvitamin D{1,25(OH)2D} in infancy and early childhood, most patients have normal calcium metabolism and normal values for circulating 25(OH)D and 1,25(OH)2D. We propose to carry out further studies of vitamin D metabolism to elucidate the mechanism(s) for abnormal vitamin D metabolism. We will determine the response of serum 1,25(OH)2D to administration of 1,25(OH)2D3. Measurement of the 1,25(OH)2D in the patients compared to normal subjects will be the primary outcome.


Condition Intervention
Williams Syndrome
Drug: Vitamin D

Study Type: Observational
Study Design: Natural History, Case Control
Official Title: Vitamin D Metabolism and the Williams Syndrome

Resource links provided by NLM:

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Age 18 years to 50 years of age, patients and normal subjects

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00013962

Locations
United States, South Carolina
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
Sponsors and Collaborators
  More Information

No publications provided

Study ID Numbers: NCRR-M01RR01070-0562
Study First Received: April 3, 2001
Last Updated: June 23, 2005
ClinicalTrials.gov Identifier: NCT00013962     History of Changes
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Disease
Heart Diseases
Growth Substances
Physiological Effects of Drugs
Nervous System Diseases
Ergocalciferols
Chromosome Disorders
Bone Density Conservation Agents
Pharmacologic Actions
Heart Valve Diseases
Mental Retardation
Vitamin D
Williams Syndrome
Pathologic Processes
Genetic Diseases, Inborn
Vitamins
Syndrome
Aortic Stenosis, Supravalvular
Neurologic Manifestations
Cardiovascular Diseases
Micronutrients
Congenital Abnormalities
Aortic Valve Stenosis
Neurobehavioral Manifestations

ClinicalTrials.gov processed this record on November 27, 2009